# Charlotte's Web Holdings, Inc.: overview CWBHF · OTC · CIK 1750155 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cwbhf.md) · [Financials](/companies/cwbhf/financials.md) · [Filings](/companies/cwbhf/filings.md) · [Insiders](/companies/cwbhf/insiders.md) Latest reported revenue: [$10.9m](/filings/0001750155-26-000117.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001750155-26-000117). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [12.6](/filings/0001750155-25-000079.md) | [12.7 d](/filings/0001750155-26-000029.md) | [12.3](/filings/0001750155-26-000077.md) | [12.8](/filings/0001750155-26-000117.md) | [11.5](/filings/0001750155-25-000079.md) | [13.3 d](/filings/0001750155-26-000029.md) | [11.2](/filings/0001750155-26-000077.md) | [10.9](/filings/0001750155-26-000117.md) | | Gross margin | % | [53.0%](/filings/0001750155-25-000079.md) | [40.2% d](/filings/0001750155-26-000029.md) | [50.8%](/filings/0001750155-26-000077.md) | [46.8%](/filings/0001750155-26-000117.md) | [38.9%](/filings/0001750155-25-000079.md) | [37.5% d](/filings/0001750155-26-000029.md) | [46.6%](/filings/0001750155-26-000077.md) | [47.5%](/filings/0001750155-26-000117.md) | | Operating margin | % | [(47.8%)](/filings/0001750155-25-000079.md) | [(43.0%) d](/filings/0001750155-26-000029.md) | [(43.6%)](/filings/0001750155-26-000077.md) | [(31.8%)](/filings/0001750155-26-000117.md) | [(45.7%)](/filings/0001750155-25-000079.md) | [(42.0%) d](/filings/0001750155-26-000029.md) | [(38.7%)](/filings/0001750155-26-000077.md) | [(40.1%)](/filings/0001750155-26-000117.md) | | Net margin | % | [(46.0%)](/filings/0001750155-25-000079.md) | [(26.6%) d](/filings/0001750155-26-000029.md) | [(50.7%)](/filings/0001750155-26-000117.md) | [(49.1%)](/filings/0001750155-26-000117.md) | [(50.6%)](/filings/0001750155-25-000079.md) | [(85.7%) d](/filings/0001750155-26-000029.md) | [(117.5%)](/filings/0001750155-26-000117.md) | [(38.0%)](/filings/0001750155-26-000117.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.04)](/filings/0001750155-26-000077.md) | [(0.04)](/filings/0001750155-26-000117.md) | [(0.04)](/filings/0001750155-25-000079.md) | not reported | [(0.08)](/filings/0001750155-26-000077.md) | [(0.02)](/filings/0001750155-26-000117.md) | | Free cash flow | $m | [(7.9) d](/filings/0001750155-25-000079.md) | [(2.0) d](/filings/0001750155-26-000029.md) | [(3.3)](/filings/0001750155-26-000077.md) | [(4.1) d](/filings/0001750155-26-000117.md) | [(5.5) d](/filings/0001750155-25-000079.md) | [(2.0) d](/filings/0001750155-26-000029.md) | [(2.8)](/filings/0001750155-26-000077.md) | [(1.0) d](/filings/0001750155-26-000117.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [96.1](/filings/0001750155-23-000021.md) | [74.1](/filings/0001750155-24-000027.md) | [63.2](/filings/0001750155-25-000006.md) | [49.7](/filings/0001750155-26-000029.md) | [49.9](/filings/0001750155-26-000029.md) | | Gross margin | % | [50.6%](/filings/0001750155-23-000021.md) | [26.2%](/filings/0001750155-24-000027.md) | [56.3%](/filings/0001750155-25-000006.md) | [42.8%](/filings/0001750155-26-000029.md) | [43.5%](/filings/0001750155-26-000029.md) | | Operating margin | % | [(153.0%)](/filings/0001750155-23-000021.md) | [(70.8%)](/filings/0001750155-24-000027.md) | [(64.3%)](/filings/0001750155-25-000006.md) | [(64.4%)](/filings/0001750155-26-000029.md) | [(40.6%)](/filings/0001750155-26-000029.md) | | Net margin | % | [(143.3%)](/filings/0001750155-23-000021.md) | [(80.0%)](/filings/0001750155-24-000027.md) | [(37.7%)](/filings/0001750155-25-000006.md) | [(60.1%)](/filings/0001750155-26-000029.md) | [(59.6%)](/filings/0001750155-26-000029.md) | | Diluted EPS | $ per share | [(0.98)](/filings/0001750155-23-000021.md) | [(0.40)](/filings/0001750155-24-000027.md) | [(0.16)](/filings/0001750155-25-000006.md) | [(0.19)](/filings/0001750155-26-000029.md) | [(0.19)](/filings/0001750155-26-000029.md) | | Free cash flow | $m | [(34.5)](/filings/0001750155-23-000021.md) | [(5.6)](/filings/0001750155-24-000027.md) | [(19.1)](/filings/0001750155-25-000006.md) | [(25.1)](/filings/0001750155-26-000029.md) | [(14.7)](/filings/0001750155-26-000029.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cwbhf/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [McIlrath & Eck, LLC](/funds/1701714.md) | 2026-03-31 | $215 | 300 | | Not compared | | [Financial Gravity Companies, Inc.](/funds/1377167.md) | 2026-06-30 | $68 | 208 | | Not compared | | [Main Street Group, LTD](/funds/1965796.md) | 2026-06-30 | $33 | 100 | | Unchanged | | [Leo H. Evart, Inc.](/funds/1920405.md) | 2026-06-30 | $1 | 3 | | Unchanged | ## Recent filings [All 285 filings](/companies/cwbhf/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-20 | 20:21 ET | [8-K](/filings/0001750155-26-000119.md) | 1.01 Entry into a material agreement | 0001750155-26-000119 | | 2026-08-13 | 11:09 ET | [10-Q](/filings/0001750155-26-000117.md) | Quarterly report, period 2026-06-30 | 0001750155-26-000117 | | 2026-08-13 | 11:07 ET | [8-K](/filings/0001750155-26-000116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001750155-26-000116 | | 2026-06-05 | 21:20 ET | [8-K](/filings/0001750155-26-000097.md) | 5.02 Departure or appointment of officers or directors | 0001750155-26-000097 | | 2026-06-03 | 21:14 ET | [8-K](/filings/0001750155-26-000094.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001750155-26-000094 | | 2026-06-01 | 21:13 ET | [8-K](/filings/0001750155-26-000080.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0001750155-26-000080 | | 2026-05-29 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001193125-26-248643.md) | Ownership report, active investor, amended | 0001193125-26-248643 | | 2026-05-13 | 11:08 ET | [10-Q](/filings/0001750155-26-000077.md) | Quarterly report, period 2026-03-31 | 0001750155-26-000077 | | 2026-05-13 | 11:07 ET | [8-K](/filings/0001750155-26-000076.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001750155-26-000076 | | 2026-04-16 | 19:02 ET | [DEF 14A](/filings/0001750155-26-000065.md) | Proxy statement, period 2025-12-31 | 0001750155-26-000065 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001750155-26-000029.md), filed Mar 31, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/9e0480dc-94a8-4c08-a17e-ab8545d34283) ## About the filer - CIK: 1750155 - Tickers: CWBHF - Exchange: OTC - SIC code: 100 Agricultural Production-Crops - State of incorporation: A1 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.